Eucrates Biomedical Acquisition Cor... (EUCR)
$10.1
0.00 (0.00%)
Rating:
Recommendation:
-
Symbol | EUCR |
---|---|
Price | $10.1 |
Beta | -0.094 |
Volume Avg. | 0.00M |
Market Cap | 42.481M |
Shares () | - |
52 Week Range | 9.803-10.1 |
1y Target Est | - |
DCF Unlevered | EUCR DCF -> | |
---|---|---|
DCF Levered | EUCR LDCF -> | |
ROE | -78.74% | Strong Sell |
ROA | 3.20% | Neutral |
Operating Margin | - | |
Debt / Equity | -105.28% | Sell |
P/E | 53.16 | Strong Buy |
P/B | -28.34 | Strong Sell |
About
Download (Excel)Eucrates Biomedical Acquisition Corp. does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It focuses to identify and acquire a business in the biomedical or healthcare-related industries in North America and Europe. The company was incorporated in 2020 and is based in New York, New York.